Astrid Børretzen

Lethal pneumonitis after docetaxel chemotherapy: Case report and review of the literature

K. Gravdal, H. P. Eikesdal, Eivind Storaas, 2013, Acta oncologica.

PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression

W. Foulkes, O. Halvorsen, L. Akslen, 2022, Nature Communications.

PRSS2 stimulates tumor growth by remodeling the TME via repression of Tsp1

W. Foulkes, O. Halvorsen, L. Akslen, 2021 .

PRSS2 promotes tumor growth and progression by repressing Tsp-1 in the tumor microenvironment via binding to LRP1

W. Foulkes, O. Halvorsen, L. Akslen, 2021, bioRxiv.

The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients

C. Beisland, K. Gravdal, O. Halvorsen, 2021, The journal of pathology. Clinical research.

A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer

S. Knappskog, C. Beisland, O. Halvorsen, 2023, Cancer Immunology, Immunotherapy.

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer

C. Beisland, K. Gravdal, O. Halvorsen, 2019, The journal of pathology. Clinical research.

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer

K. Gravdal, O. Halvorsen, I. Haldorsen, 2023, Scientific reports.